Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 4 Country / region: Netherlands Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20062
20072
20081
20093
20104
20111
20121
20133
20142
20152
20165
20173
20181
20191
20203
20211
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated4
Unknown status4
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amsterdam UMC, location VUmc9
Sanofi5
AstraZeneca3
GlaxoSmithKline3
Novo Nordisk A/S3
Eli Lilly and Company2
Ingrid Jazet2
Leiden University Medical Center2
M.H.H. Kramer2
Radboud University Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 242
Diabetes Mellitus10
Diabetic Nephropathies5
Obesity5
Albuminuria3
Fatty Liver3
Insulin Resistance3
Cardiovascular Diseases2
Diabetes Complications2
Metabolic Syndrome2

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.